Cytokinetics (CYTK) - Shares outstanding

Number of shares outstanding as of December 2025 : 119,982,000

According to Cytokinetics 's latest financial reports and stock price the company's current number of shares outstanding is 119,982,000. At the end of 2025 the company had 119,982,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Cytokinetics from 2013 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.11 B	1.62%
2024	0.11 B	19.19%
2023	99.06 M	4.63%
2022	94.68 M	12.6%
2021	84.08 M	18.71%
2020	70.83 M	20.79%
2019	58.64 M	7.22%
2018	54.68 M	1.41%
2017	53.92 M	32.89%
2016	40.58 M	3.79%
2015	39.09 M	6.39%
2014	36.74 M	23.17%
2013	29.83 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Ligand Pharmaceuticals LGND	19,578,000	-83.68%	🇺🇸 USA
Trevena TRVN	852,801	-99.29%	🇺🇸 USA
Acorda Therapeutics ACOR	1,242,000	-98.96%	🇺🇸 USA
Amgen AMGN	538,000,000	348.40%	🇺🇸 USA
Array Technologies ARRY	152,727,000	27.29%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Cytokinetics (CYTK)

Number of shares outstanding as of December 2025 : 119,982,000